Patents by Inventor Kegan Moneghetti

Kegan Moneghetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof
    Patent number: 11929171
    Abstract: Methods to compute glycemia tests and applications thereof are described. Additional methods to compute risk of atherosclerotic cardiovascular disease and applications thereof are described. Generally, systems utilize analyte measurements to determine a glycemic status or cardiovascular disease risk, which can be used as a basis to treat individuals.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: March 12, 2024
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Sophia Miryam Schüssler-Fiorenza Rose, Kevin Contrepois, Wenyu Zhou, Samson Mataraso, Tejaswini Mishra, Michael Snyder, Kegan Moneghetti, Francois Haddad
  • Methods for Evaluation and Treatment of Glycemic Dysregulation and Atherosclerotic Cardiovascular Disease and Applications Thereof
    Publication number: 20200227166
    Abstract: Methods to compute glycemia tests and applications thereof are described. Additional methods to compute risk of atherosclerotic cardiovascular disease and applications thereof are described. Generally, systems utilize analyte measurements to determine a glycemic status or cardiovascular disease risk, which can be used as a basis to treat individuals.
    Type: Application
    Filed: October 18, 2019
    Publication date: July 16, 2020
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Sophia Miryam Schüssler-Fiorenza Rose, Kevin Contrepois, Wenyu Zhou, Samson Mataraso, Tejaswini Mishra, Michael Snyder, Kegan Moneghetti, Francois Haddad